These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20951042)

  • 1. Developmental defects and neuromuscular alterations due to mitofusin 2 gene (MFN2) silencing in zebrafish: a new model for Charcot-Marie-Tooth type 2A neuropathy.
    Vettori A; Bergamin G; Moro E; Vazza G; Polo G; Tiso N; Argenton F; Mostacciuolo ML
    Neuromuscul Disord; 2011 Jan; 21(1):58-67. PubMed ID: 20951042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A.
    Cartoni R; Martinou JC
    Exp Neurol; 2009 Aug; 218(2):268-73. PubMed ID: 19427854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.
    Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO
    Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal Transport Defects in a Mitofusin 2 Loss of Function Model of Charcot-Marie-Tooth Disease in Zebrafish.
    Chapman AL; Bennett EJ; Ramesh TM; De Vos KJ; Grierson AJ
    PLoS One; 2013; 8(6):e67276. PubMed ID: 23840650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene.
    Lawson VH; Graham BV; Flanigan KM
    Neurology; 2005 Jul; 65(2):197-204. PubMed ID: 16043786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2).
    Engelfried K; Vorgerd M; Hagedorn M; Haas G; Gilles J; Epplen JT; Meins M
    BMC Med Genet; 2006 Jun; 7():53. PubMed ID: 16762064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mutations in the mitofusin 2 gene are the most common cause of Charcot-Marie-Tooth type 2 disease].
    Sołtysińska E; Kabzińska D; Kochański A
    Neurol Neurochir Pol; 2007; 41(4):350-4. PubMed ID: 17874344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2.
    Züchner S; De Jonghe P; Jordanova A; Claeys KG; Guergueltcheva V; Cherninkova S; Hamilton SR; Van Stavern G; Krajewski KM; Stajich J; Tournev I; Verhoeven K; Langerhorst CT; de Visser M; Baas F; Bird T; Timmerman V; Shy M; Vance JM
    Ann Neurol; 2006 Feb; 59(2):276-81. PubMed ID: 16437557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations.
    Calvo J; Funalot B; Ouvrier RA; Lazaro L; Toutain A; De Mas P; Bouche P; Gilbert-Dussardier B; Arne-Bes MC; Carrière JP; Journel H; Minot-Myhie MC; Guillou C; Ghorab K; Magy L; Sturtz F; Vallat JM; Magdelaine C
    Arch Neurol; 2009 Dec; 66(12):1511-6. PubMed ID: 20008656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A.
    Cartoni R; Arnaud E; Médard JJ; Poirot O; Courvoisier DS; Chrast R; Martinou JC
    Brain; 2010 May; 133(Pt 5):1460-9. PubMed ID: 20418531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial coupling defect in Charcot-Marie-Tooth type 2A disease.
    Loiseau D; Chevrollier A; Verny C; Guillet V; Gueguen N; Pou de Crescenzo MA; Ferré M; Malinge MC; Guichet A; Nicolas G; Amati-Bonneau P; Malthièry Y; Bonneau D; Reynier P
    Ann Neurol; 2007 Apr; 61(4):315-23. PubMed ID: 17444508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A.
    Franco A; Dang X; Zhang L; Molinoff PB; Dorn GW
    J Pharmacol Exp Ther; 2022 Nov; 383(2):137-148. PubMed ID: 36507849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early onset Charcot-Marie-Tooth neuropathy type 2A and severe developmental delay: expanding the clinical phenotype of MFN2-related neuropathy.
    Tufano M; Cappuccio G; Terrone G; Manganelli F; Pisciotta C; Geroldi A; Capponi S; Del Giudice E
    J Peripher Nerv Syst; 2015 Dec; 20(4):415-8. PubMed ID: 26307494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the mitofusin 2 R94W mutation in a knock-in mouse model.
    Strickland AV; Rebelo AP; Zhang F; Price J; Bolon B; Silva JP; Wen R; Züchner S
    J Peripher Nerv Syst; 2014 Jun; 19(2):152-64. PubMed ID: 24862862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mitofusin 2 as a crucial peripheral nervous system protein and a common regulator of cell metabolism].
    Kawalec M; Kotruchow K; Kochański A; Zabłocka B
    Postepy Biochem; 2011; 57(2):215-21. PubMed ID: 21913423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system.
    Pich S; Bach D; Briones P; Liesa M; Camps M; Testar X; Palacín M; Zorzano A
    Hum Mol Genet; 2005 Jun; 14(11):1405-15. PubMed ID: 15829499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic spectrum of MFN2 mutations in the Spanish population.
    Casasnovas C; Banchs I; Cassereau J; Gueguen N; Chevrollier A; Martínez-Matos JA; Bonneau D; Volpini V
    J Med Genet; 2010 Apr; 47(4):249-56. PubMed ID: 19889647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of disease and clinical features of mutations of the gene for mitofusin 2: an important cause of hereditary peripheral neuropathy with striking clinical variability in children and adults.
    Ouvrier R; Grew S
    Dev Med Child Neurol; 2010 Apr; 52(4):328-30. PubMed ID: 20163430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human mitofusin 2 mutation can cause mitophagic cardiomyopathy.
    Franco A; Li J; Kelly DP; Hershberger RE; Marian AJ; Lewis RM; Song M; Dang X; Schmidt AD; Mathyer ME; Edwards JR; Strong CG; Dorn GW
    Elife; 2023 Nov; 12():. PubMed ID: 37910431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing the phenotypic manifestations of MFN2 R104W mutation in Charcot-Marie-Tooth type 2.
    Genari AB; Borghetti VH; Gouvêa SP; Bueno KC; dos Santos PL; dos Santos AC; Barreira AA; Lourenço CM; Marques W
    Neuromuscul Disord; 2011 Jun; 21(6):428-32. PubMed ID: 21531138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.